Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England-Reference-Cited by-同舟云学术

Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England

Published:2024-01-24 Issue: Volume: Page:
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Brown Janet^ORCID,Harrow Brooke,Marciniak Anne,McCarthy Christine,Houchard Aude,Cirneanu Lori,Protheroe Andrew

Funder

Ipsen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-023-00415-w.pdf

Reference47 articles.

1. International Agency for Research on Cancer World Health Organization. Globocan 2020 Kidney fact sheet. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/29-Kidney-fact-sheet.pdf. [Accessed 20 Jul 2023].

2. International Agency for Research on Cancer World Health Organization. Globocan 2020 United Kingdom fact sheet. Available from: https://gco.iarc.fr/today/data/factsheets/populations/826-united-kingdom-fact-sheets.pdf. Accessed 20 Jul 2023.

3. Cancer Research UK. Kidney cancer statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/kidney-cancer. Accessed 21 Nov 2021.

4. Graves A, Hessamodini H, Wong G, Lim WH. Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities. Immunotargets Ther. 2013;2:73–90. https://doi.org/10.2147/ITT.S31426.

5. Pandey J, Syed W. Renal cancer. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558975/. Accessed 2 Feb 2022.